The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 339:347-348 July 30, 1998 Number 5
NextNext

CDKN2A Mutations in Multiple Primary Melanomas

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Monzon, J.
-PubMed Citation
To the Editor: The clinical relevance of the conclusion of Monzon et al. (March 26 issue)1 that patients with multiple melanomas have a germ-line mutation of the CDKN2A gene that predisposes them to melanoma is difficult to ascertain because no information is provided on the incidence of this mutation in patients who do not have multiple primary melanomas or in the normal population. Consequently, the possibility that this mutation is unrelated to the pathogenesis of melanoma has not been excluded.

In any case, the mutation appears to be of minor clinical relevance, even if it is associated with multiple melanomas, . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.